AstraZeneca is a leader in cancer treatments with FDA-approved drugs. Read why AZN stock is still a 'Buy' and why the company’s future looks bright.

UBS analyst Thomas Wadewitz increased the price target for Knight Transportation (NYSE: NYSE:KNX) shares to $63.00, up from ...

In a report released today, Tabitha Foo from DBS maintained a Buy rating on United Airlines Holdings (UAL – Research Report), with a price ...

Wells Fargo analyst Michael Blum has maintained their bullish stance on GEV stock, giving a Buy rating today.Invest with Confidence: Follow ...

UBS analyst Joseph Spak increased the price target for Aptive PLC (NYSE:APTV) to $82 from the previous $73, while retaining a Buy rating on the stock. Currently trading at $64.13, Aptiv appears ...

Stocks trading under $10 can be attractive for investors looking to scoop up some cheap shares. Unfortunately, quality stocks ...

The latest Apple stock downgrade centers around iPhone sales and the weakening consumer electronics market. Here's what ...

Stock ratings can range from simple “buy” and “sell” ratings to “equal weight” and “outperform” ratings. Here’s a quick overview of how analysts rate stocks. A “buy” rating ...

If you have an extra $1,000 sitting in a savings or checking account, one of the best ways to earn a return on that money is ...

UBS Maintains Buy on Netflix, Raises Price Target to $1150 Analyst ratings measure the expected performance of a stock during a given time period. Analysts and brokerage firms often use ratings ...